top of page

Dr Chanakya Sharma

MBBS (UWA) MClinRes (UWA) FRACP (Rheumatology) FRACP (General Medicine)

Chanakya is a Perth trained Rheumatologist who believes in providing world class holistic care for patients with rheumatological conditions. 

He has public appointments at Fiona Stanley Hospital, Royal Perth Hospital and Rockingham General Hospital.

 

Chanakya works in private practice at Joints West Rheumatology at Wexford Medical Centre. He is always happy to accomodate requests from colleagues for urgent reviews. Please click on "Contact details" on the top right for more information. 

​

​

Areas of Expertise

Rheumatoid arthritis
Psoriatic arthritis
Ankylosing Spondylitis
Enteropathic Arthritis 
Osteoarthritis
Systemic Lupus Erythematosus
Vasculitis
Myositis
Connective Tissue Disorders
Gout
Auto-Inflammatory conditions
Undiagnosed joint pains

Chanakya completed his medical degree at the University of Western Australia in 2009. He underwent advanced physician training in Rheumatology and General Medicine across tertiary centres of excellence for five years. 

​

During this time he also conducted research on various topics including Inflammatory arthritis, Systemic Lupus Erythematosus, Vasculitis and Gout. His research has been published in peer reviewed journals (including first author publications in Annals of The Rheumatic Diseases - the highest impact factor rheumatology journal) and has presented his research at national and international conferences.

 

Chanakya has also completed a four year Master of Clinical Research degree at UWA.   

​

Chanakya has been the secretary of the WA branch of the Australian Rheumatology Association and also a board member of the Advanced Training Committee for Rheumatology at the Royal Australasian College of Physicians.

​

​

Services
Contact

Selected Publications

  • Sharma, C., Morgan, K., Hill, C. L., & Keen, H. (2021). Assessing the accuracy of discharge coding for gout, using the International Classification of Disease, at two tertiary teaching hospitals in Perth. Tasman Medical Journal, 3(1), 76-80. https://tasmanmedicaljournal.com/2020/12/assessing-the-accuracy-of-discharge-coding-for-gout-using-the-international-classification-of-disease-at-two-tertiary-teaching-hospitals-in-perth/

  • Sharma C, Whittle S, Delir Haghighi P, Burstein F, Keen H. Response to ‘Correspondence on ‘Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis’’ by Reuter et al. Annals of the Rheumatic Diseases. 2021:annrheumdis-2020.

  • Sharma C, Whittle S, Delir Haghighi P, Burstein F, Sa'adon R, Keen H. Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis. Annals of the rheumatic diseases. 2020;79.

  • Sharma C, Whittle S, Delir Haghighi P, Burstein F, Keen H. Sentiment analysis of social media posts on pharmacotherapy: A scoping review. Pharmacology Research & Perspectives. 2020;8.

  • Loh K, Sharma C, Keen H. Australian tertiary institutions are failing people with gout. Internal Medicine Journal. 2020;50:386-.

  • Inderjeeth C, Habib P, Sharma C, Nossent J. Systemic lupus erythematosus: reducing life-threatening progression MedicineToday 2018; 19(9): 31-41

  • Sharma C, Raymond W, Eilertsen G, Nossent J. Achieving Lupus Low Disease Activity State (LLDAS‐50) is associated with both reduced damage accrual and mortality in patients with Systemic Lupus Erythematosus. Arthritis Care & Research. 2019;72.

  • Sharma C, Keen H. Ten-year retrospective review of the incidence of serious infections in patients on biologic disease modifying agents for rheumatoid arthritis in three tertiary hospitals in Western Australia: serious infections in bDMARD RA patients. Internal Medicine Journal. 2018;49.

bottom of page